NEXIEN BIOPHARMA, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Glendale, CO
SEC filing record 1 source field available
Fiscal year end
30 June
NEXIEN BIOPHARMA, INC. has filed 201 SEC EDGAR filings since 14 Nov 2014

SEC filing history

Showing 151-175 of 201 matching filings.

Per page
25
Current page
7
4

PRIMARY DOCUMENT

Filing date
30 Nov 2017
Reporting date
29 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
30 Nov 2017
Reporting date
29 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
30 Nov 2017
Reporting date
29 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
30 Nov 2017
Reporting date
29 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
30 Nov 2017
Reporting date
29 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-55320

CURRENT REPORT

Filing date
29 Nov 2017
Reporting date
29 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14C File 000-55320

DEFINITIVE INFORMATION STATEMENT

Filing date
06 Nov 2017
Reporting date
06 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-55320

10-Q filing

Filing date
03 Nov 2017
Reporting date
30 Sep 2017
Next action
Verify source filing
PRE 14C File 000-55320

PRELIMINARY INFORMATION STATEMENT

Filing date
26 Oct 2017
Reporting date
26 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
20 Oct 2017
Reporting date
13 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-90143

SC 13D filing

Filing date
18 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Oct 2017
Reporting date
13 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
18 Oct 2017
Reporting date
26 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
18 Oct 2017
Reporting date
13 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Oct 2017
Reporting date
13 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
17 Oct 2017
Reporting date
26 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Oct 2017
Reporting date
13 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
17 Oct 2017
Reporting date
26 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
17 Oct 2017
Reporting date
13 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-55320

8-K filing

Filing date
16 Oct 2017
Reporting date
13 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
05 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
25 Sep 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
30 Aug 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
16 Aug 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-55320

CURRENT REPORT

Filing date
09 Aug 2017
Reporting date
08 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .